VRIO Analysis of Nymox Pharmaceutical Corporation
Posted by Zachary Edwards on Mar-22-2018
The VRIO Analysis of Nymox Pharmaceutical Corporation will look at each of its internal resources one by one to assess whether these provide sustained competitive advantage. The Nymox Pharmaceutical Corporation VRIO Analysis also mentions at each stage whether these resources could be improved to provide a greater competitive advantage. Lastly, the resources analysed are summarised as to whether they offer sustained competitive advantage, has an unused competitive advantage, temporary competitive advantage, competitive parity or competitive disadvantage.
Valuable
- The Nymox Pharmaceutical Corporation VRIO Analysis shows that the financial resources of Nymox Pharmaceutical Corporation are highly valuable as these help in investing into external opportunities that arise. These also help Nymox Pharmaceutical Corporation in combating external threats.
- According to the VRIO Analysis of Nymox Pharmaceutical Corporation, its local food products are a valuable resource as these are highly differentiated. This makes the perceived value for these by customers high. These are also valued more than the competition by customers due to the differentiation in these products.
- The Nymox Pharmaceutical Corporation VRIO Analysis shows that Nymox Pharmaceutical Corporation's employees are a valuable resource to the firm. A significant portion of the workforce is highly trained, and this leads to more productive output for the organisation. The employees are also loyal, and retention levels for the organisation are high. All of this translates into greater value for the end consumers of Nymox Pharmaceutical Corporation's products.
- According to the VRIO Analysis of Nymox Pharmaceutical Corporation, its patents are a valuable resource as these allow the firm to sell its products without competitive interference. This results in greater revenue for Nymox Pharmaceutical Corporation. These patents also provide Nymox Pharmaceutical Corporation with licensing revenue when it licenses these patents out to other manufacturers.
- The Nymox Pharmaceutical Corporation VRIO Analysis shows that Nymox Pharmaceutical Corporation’s distribution network is a valuable resource. This helps it in reaching out to more and more customers. This ensures greater revenues for Nymox Pharmaceutical Corporation. It also ensures that promotion activities translate into sales as the products are easily available.
- According to the VRIO Analysis of Nymox Pharmaceutical Corporation, its cost structure is not a valuable resource. This is because the methods of production lead to greater costs than that of competition, which affects the overall profits of the firm. Therefore, its cost structure is a competitive disadvantage that needs to be worked on.
- The Nymox Pharmaceutical Corporation VRIO Analysis shows that the research and development at Nymox Pharmaceutical Corporation is not a valuable resource. This is because research and development are costing more than the benefits it provides in the form of innovation. There have been very few innovative features and breakthrough products in the past few years. Therefore, research and development are a competitive disadvantage for Nymox Pharmaceutical Corporation. It is recommended that the research and development teams are improved, and costs are cut for these.
Rare
- The financial resources of Nymox Pharmaceutical Corporation are found to be rare according to the VRIO Analysis of Nymox Pharmaceutical Corporation. Strong financial resources are only possessed by a few companies in the industry.
- The local food products are found to be not rare as identified by Nymox Pharmaceutical Corporation VRIO Analysis. These are easily provided in the market by other competitors. This means that competitors can use these resources in the same way as Nymox Pharmaceutical Corporation and inhibit competitive advantage. This means that the local food products result in competitive parity for Nymox Pharmaceutical Corporation. As this resource is valuable, Nymox Pharmaceutical Corporation can still make use of this resource.
- The employees of Nymox Pharmaceutical Corporation are a rare resource as identified by the VRIO Analysis of Nymox Pharmaceutical Corporation. These employees are highly trained and skilled, which is not the case with employees in other firms. The better compensation and work environment ensure that these employees do not leave for other firms.
- The patents of Nymox Pharmaceutical Corporation are a rare resource as identified by the Nymox Pharmaceutical Corporation VRIO Analysis. These patents are not easily available and are not possessed by competitors. This allows Nymox Pharmaceutical Corporation to use them without interference from the competition.
- The distribution network of Nymox Pharmaceutical Corporation is a rare resource as identified by the VRIO Analysis of Nymox Pharmaceutical Corporation. This is because competitors would require a lot of investment and time to come up with a better distribution network than that of Nymox Pharmaceutical Corporation. These are also possessed by very few firms in the industry.
Imitable
- The financial resources of Nymox Pharmaceutical Corporation are costly to imitate as identified by the Nymox Pharmaceutical Corporation VRIO Analysis. These resources have been acquired by the company through prolonged profits over the years. New entrants and competitors would require similar profits for a long period of time to accumulate these amounts of financial resources.
- The local food products are not that costly to imitate as identified by the VRIO Analysis of Nymox Pharmaceutical Corporation. These can be acquired by competitors as well if they invest a significant amount in research and development. These also do not require years long experience. Therefore, the local food products by Nymox Pharmaceutical Corporation provide it with a temporary competitive advantage that competitors can too acquire in the long run.
- The employees of Nymox Pharmaceutical Corporation are also not costly to imitate as identified by the Nymox Pharmaceutical Corporation VRIO Analysis. This is because other firms can also train their employees to improve their skills. These companies can also hire employees from Nymox Pharmaceutical Corporation by offering better compensation packages, work environment, benefits, growth opportunities etc. This makes the employees of Nymox Pharmaceutical Corporation a resource that provides a temporary competitive advantage. Competition can acquire these in the future.
- The patents of Nymox Pharmaceutical Corporation are very difficult to imitate as identified by the VRIO Analysis of Nymox Pharmaceutical Corporation. This is because it is not legally allowed to imitate a patented product. Similar resources to be developed and getting a patent for them is also a costly process.
- The distribution network of Nymox Pharmaceutical Corporation is also very costly to imitate by competition as identified by the Nymox Pharmaceutical Corporation VRIO Analysis. This has been developed over the years gradually by Nymox Pharmaceutical Corporation. Competitors would have to invest a significant amount if they are to imitate a similar distribution system.
Organisation
- The financial resources of Nymox Pharmaceutical Corporation are organised to capture value as identified by the VRIO Analysis of Nymox Pharmaceutical Corporation. These resources are used strategically to invest in the right places; making use of opportunities and combatting threats. Therefore, these resources prove to be a source of sustained competitive advantage for Nymox Pharmaceutical Corporation.
- The Patents of Nymox Pharmaceutical Corporation are not well organised as identified by the Nymox Pharmaceutical Corporation VRIO Analysis. This means that the organisation is not using these patents to their full potential. An unused competitive advantage exists that can be changed into a sustainable competitive advantage if Nymox Pharmaceutical Corporation starts selling patented products before the patents expire.
- The distribution network of Nymox Pharmaceutical Corporation is organised as identified by the VRIO Analysis of Nymox Pharmaceutical Corporation. Nymox Pharmaceutical Corporation uses this network to reach out to its customers by ensuring that products are available on all of its outlets. Therefore, these resources prove to be a source of sustained competitive advantage for Nymox Pharmaceutical Corporation.
From the VRIO Analysis of Nymox Pharmaceutical Corporation, it was identified that the financial resources and distribution network provide a sustained competitive advantage. The patents are a source of unused competitive advantage. There exists a temporary competitive advantage for employees. There exists a competitive parity for local food products. Lastly, the cost structure of Nymox Pharmaceutical Corporation is a competitive disadvantage. Research and Development is also a competitive disadvantage.
Warning! This article is only an example and cannot be used for research or reference purposes. If you need help with something similar, please submit your details here.
Ahmad Hakim
5.0
This service was able to complete the assignment properly. Received the project in a standard manner!
Helen Edison
5.0
This company knows how to care for its clients. Essay was created in the top-notch writing style and I wish may I have the same style to put ideas into words. Thanks!
Qing Ying
5.0
The staff is very great and the writer didn't give the chance to complain here. Great site and very helpful!
Leo Zahar
5.0
There was no error in the assignment to complain about. Amazing experience. Thanks a lot!
Next Articles
- Oasmia Pharmaceutical AB (publ) Vrio Analysis
- ObsEva SA Vrio Analysis
- Ocera Therapeutics, Inc. Vrio Analysis
- Ocular Therapeutix, Inc. Vrio Analysis
- Orthofix International N.V. Vrio Analysis
- Oragenics, Inc. Vrio Analysis
- OncoGenex Pharmaceuticals, Inc. Vrio Analysis
- Ohr Pharmaceutical, Inc. Vrio Analysis
- OncoMed Pharmaceuticals, Inc. Vrio Analysis
- Omeros Corporation Vrio Analysis
Previous Articles
- Nxstage Medical, Inc. Vrio Analysis
- Novus Therapeutics, Inc. Vrio Analysis
- Invitae Corporation Vrio Analysis
- Novartis AG Vrio Analysis
- Nevro Corp. Vrio Analysis
- Novo Nordisk A/S Vrio Analysis
- Nivalis Therapeutics, Inc. Vrio Analysis
- Novelion Therapeutics Inc. Vrio Analysis
- InVivo Therapeutics Holdings Corp. Vrio Analysis
- Nexvet Biopharma Public Limited Company Vrio Analysis
Be a great writer or hire a greater one!
Academic writing has no room for errors and mistakes. If you have BIG dreams to score BIG, think out of the box and hire Case48 with BIG enough reputation.
Our Guarantees
Interesting Fact
Most recent surveys suggest that around 76 % students try professional academic writing services at least once in their lifetime!